Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
MedAvante-ProPhase is a specialized clinical trial services and technology company focused on Central Nervous System (CNS) and behavioral health research. As a division of WCG, the company provides electronic clinical outcome assessments (eCOA), independent central ratings, and rater training to enhance signal detection and data quality. Their proprietary Virgil platform facilitates digital data collection and clinical endpoint management, reducing variability in complex global trials. The organization serves major pharmaceutical companies and CROs, helping to bring new treatments for neurology and psychiatry to market more efficiently. By leveraging a global network of expert clinicians, they ensure standardized assessment across diverse study sites.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on MedAvante-ProPhase.